HealthHelus psychedelic depression drug succeeds in trial amid safety scrutiny
Helus Pharma said its experimental psychedelic drug significantly eased depression symptoms in a late-stage trial. Its US-listed shares fell more than 15% as investors focused on safety concerns, including a reported suicide attempt in the study.
Helus psychedelic depression drug succeeds in trial amid safety scrutiny
